# A Phase II Trial of Combined Hydroxychloroquine and Sirolimus in Soft Tissue Sarcoma

> **NCT01842594** · PHASE2 · TERMINATED · sponsor: **Shin Kong Wu Ho-Su Memorial Hospital** · enrollment: 13 (actual)

## Conditions studied

- Sarcoma

## Interventions

- **DRUG:** Sirolimus and hydroxychloroquine

## Key facts

- **NCT ID:** NCT01842594
- **Lead sponsor:** Shin Kong Wu Ho-Su Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-08
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Most patients completed only the primary objective (PET) and not went throught the secondary outcome (efficacy phase) of 8wks period.
- **Last updated:** 2015-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01842594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01842594, "A Phase II Trial of Combined Hydroxychloroquine and Sirolimus in Soft Tissue Sarcoma". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01842594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*